TMCI Price / FCF | Treace Medical Concepts, Inc.

TREACE MEDICAL CONCEPTS, INC. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for the quarter ending 2026-06-30 was -10.27, a change of 2.44 year-over-year.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for the quarter ending 2026-03-31 was -3.35, a change of 10.87 year-over-year.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for the quarter ending 2025-12-31 was -5.32, a change of 4.19 year-over-year.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for the quarter ending 2025-09-30 was -16.09, a change of -7.73 year-over-year.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for fiscal 2026 was -10.27.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for fiscal 2025 was -5.32, a change of 4.19 from fiscal 2024.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for fiscal 2024 was -9.51, a change of 7.6 from fiscal 2023.
TREACE MEDICAL CONCEPTS, INC. price-fcf ratio for fiscal 2023 was -17.1, a change of 11.01 from fiscal 2022.

Available history: 2021-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-10.27	$257.22M	-$25.05M
2026-03-31	-3.35	$86.87M	-$25.96M
2025-12-31	-5.32	$156.75M	-$29.49M
2025-09-30	-16.09	$423.89M	-$26.34M
2025-06-30	-12.71	$370.51M	-$29.15M
2025-03-31	-14.22	$525.37M	-$36.96M
2024-12-31	-9.51	$463.49M	-$48.76M
2024-09-30	-8.36	$361.2M	-$43.2M
2024-06-30	-9.96	$413.47M	-$41.5M
2024-03-31	-21.02	$808.18M	-$38.44M
2023-12-31	-17.1	$787.31M	-$46.03M
2023-09-30	-15.53	$807.67M	-$52.01M
2023-06-30	-30.07	$1.57B	-$52.33M
2023-03-31	-27.81	$1.54B	-$55.5M
2022-12-31	-28.12	$1.28B	-$45.49M
2022-09-30	-28.86	$1.22B	-$42.45M
2022-06-30	-20.21	$794.31M	-$39.31M
2022-03-31	-37.36	$1.05B	-$27.98M
2021-12-31	-50.76	$1.01B	-$19.9M
2021-09-30	-110.18	$1.42B	-$12.89M
2021-06-30	-179.66	$1.25B	-$6.94M

Annual Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-10.27	$257.22M	-$25.05M
2025-12-31	-5.32	$156.75M	-$29.49M
2024-12-31	-9.51	$463.49M	-$48.76M
2023-12-31	-17.1	$787.31M	-$46.03M
2022-12-31	-28.12	$1.28B	-$45.49M
2021-12-31	-50.76	$1.01B	-$19.9M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Mobia Medical, Inc. (MOBI)	United States	$0.293B
TriSalus Life Sciences, Inc. (TLSI)	United States	$0.283B	-9.92
Embecta Corp. (EMBC)	United States	$0.319B	2.10
Cytosorbents Corp (CTSO)	United States	$0.274B	-1.29
ORASURE TECHNOLOGIES INC (OSUR)	United States	$0.272B	-6.26
Anika Therapeutics, Inc. (ANIK)	United States	$0.272B	-51.71
InfuSystem Holdings, Inc (INFU)	United States	$0.253B	22.52
UTAH MEDICAL PRODUCTS INC (UTMD)	United States	$0.238B	20.93
SHOULDER INNOVATIONS, INC. (SI)	United States	$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)	United States	$0.356B	-4.39